Eurobio Scientific SA
Research Eurobio Scientific SA (ALERS) on Bullrun: market cap EUR 201.37M, P/E 42.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALERS
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 201.37M
- P/E42.6
- Financial periodFY2025
- RevenueEUR 168.60M
- Revenue growth9.1%
- Net incomeEUR 4.87M
- Free cash flowEUR 6.28M
- Gross margin45.6%
Valuation Snapshot
latest market cap is EUR 201.37M; P/E is 42.6.
Peer valuation comparison
Latest P/E is 42.55x versus a Healthcare sector median of 24.46x (74.0% above).
Latest P/E is 42.55x versus a France median of 15.25x (179.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 168.60M | EUR 4.87M | EUR 6.28M | 45.6% | 0.47 | EUR 20.32M | EUR 16.02M | EUR 183.92M |
| FY2024 | EUR 154.56M | EUR 4.00M | EUR 13.45M | 46.3% | 0.39 | EUR 21.77M | EUR 34.06M | EUR 178.86M |
| FY2023 | EUR 130.00M | EUR 4.84M | EUR 22.71M | 43.7% | 0.43 | EUR 49.30M | EUR 101.33M | EUR 175.17M |
| FY2022 | EUR 152.61M | EUR 24.94M | EUR 40.24M | 46.5% | 2.2 | EUR 47.49M | EUR 114.31M | EUR 172.98M |
| FY2021 | EUR 184.71M | EUR 60.54M | EUR 64.07M | 55.3% | 5.57 | EUR 92.92M | EUR 15.69M | EUR 160.87M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 201.37M | 42.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Eurobio Scientific SA
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Eurobio Scientific SA's market cap?
Eurobio Scientific SA's market capitalization is EUR 201.37M.
What is Eurobio Scientific SA's P/E ratio?
Eurobio Scientific SA's price-to-earnings (P/E) ratio is 42.6.
What does Eurobio Scientific SA do?
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences.